MS Archives -

Pharmaceutical marketing budgets are going through a period of readjustment as companies explore and exploit a myriad of

Digitally engaging doctors around the world

https://pharmaphorum.com/whitepapers/digitally-engaging-doctors-around-the-world/

Patients/ Views & Analysis/ Views and analysis

Bridging the gap between pharma and the NHS in MS

mike.hammerton@pharmaphorum.com Biogen, MS, multiple sclerosis, NHS 0 Comment

Janette Curlis is a Multiple Sclerosis Nurse Advisor (MSNA) at Biogen, helping to support the company’s Multiple Sclerosis

Bridging the gap between pharma and the NHS in MS

https://pharmaphorum.com/views-analysis-patients/bridging-gap-between-pharma-nhs-in-ms/

Patients/ Views & Analysis/ Views and analysis

Changing how we talk about clinical trials

mike.hammerton@pharmaphorum.com clinical trials, MS, multiple sclerosis, patient insights 0 Comment

Multiple sclerosis (MS) patient Elizabeth Kinder tells us why she participated in a clinical trial and why the

Changing how we talk about clinical trials

https://pharmaphorum.com/views-analysis-patients/changing-talk-clinical-trials-ms/

Sales and Marketing/ Views & Analysis/ Views and analysis

Is Tecfidera’s patent win a pyrrhic victory for Biogen?

George Underwood aducanumab, Alzheimer's, Biogen, MS, Q4, Tecfidera 0 Comment

Shares in Biogen jumped last week after the company successfully defended its blockbuster MS drug Tecfidera from a

Is Tecfidera’s patent win a pyrrhic victory for Biogen?

https://pharmaphorum.com/views-analysis-sales-marketing/tecfideras-patent-pyrrhic-victory-biogen/

Patients/ Views & Analysis/ Views and analysis

Getting MS diagnosis right

George Underwood MS, multiple sclerosis, patient insights, Trishna Bharadia 0 Comment

MS advocate Trishna Bharadia explains how diagnosis needs to change and why pharma shouldn’t be using the word

Getting MS diagnosis right

https://pharmaphorum.com/views-analysis-patients/getting-ms-diagnosis-right/

Patients/ Views & Analysis/ Views and analysis

Addressing MS’ two-tier healthcare system is about ‘social justice’

Amanda Barrell MS, MS Trust, multiple sclerosis, Ocrevus 0 Comment

NICE has reversed its decision not to approve a new drug that offers hope to thousands of people

Addressing MS’ two-tier healthcare system is about ‘social justice’

https://pharmaphorum.com/views-analysis-patients/ms-two-tier-healthcare-system/

Digital/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis

Case study: Ensuring safety by digitally linking prescription management to blood monitoring

Amanda Barrell blood monitoring, MS, MS Trust, QuDoS, QuDoS in MS 0 Comment

Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care. But

Case study: Ensuring safety by digitally linking prescription management to blood monitoring

https://pharmaphorum.com/views-analysis-digital/ms-case-study-safety-digitally-linking-prescription-management/

Articles/ Healthcare/ UK & Europe/ Views and analysis

‘Listen to your patients’: the best MS care honoured at QuDoS

Andrew McConaghie MS, multiple sclerosis, QuDoS 0 Comment

Best healthcare professionals working in multiple sclerosis (MS) honoured QuDoS awards.

‘Listen to your patients’: the best MS care honoured at QuDoS

https://pharmaphorum.com/views-and-analysis/best-ms-care-honoured-qudos-awards/

Articles/ Healthcare/ UK & Europe/ Views and analysis

5 questions: making Multiple Sclerosis care more patient-centric

Linda Banks MS, multiple sclerosis, patient advocate, patient centricity, patient-centric, patients 0 Comment

Trishna Bharadia, Multiple Sclerosis patient advocate, wants to make MS care more patient-centric.

5 questions: making Multiple Sclerosis care more patient-centric

https://pharmaphorum.com/views-and-analysis/multiple-sclerosis-patient-centric/

Trending

MS

Login